Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor–Induced Myocarditis

BACKGROUND: Myocarditis is a dreaded and unpredictable complication of immune checkpoint inhibitors (ICI). We sought to determine whether routinely measured biomarkers could be helpful in monitoring for ICI myocarditis. OBJECTIVES: The authors examined biomarker trends of patients on ICI and their a...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasbinder, Alexi, Chen, YeeAnn, Procureur, Adrien, Gradone, Allison, Azam, Tariq U., Perry, Daniel, Shadid, Husam, Anderson, Elizabeth, Catalan, Tonimarie, Blakely, Pennelope, Nelapudi, Namratha, Fardous, Mohamad, Bretagne, Marie C., Adie, Sarah K., Pogue, Kristen T., Leja, Monika, Yentz, Sarah, Schneider, Bryan, Fecher, Leslie A., Lao, Christopher D., Salem, Joe-Elie, Hayek, Salim S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830199/
https://www.ncbi.nlm.nih.gov/pubmed/36636441
http://dx.doi.org/10.1016/j.jaccao.2022.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830199/
https://www.ncbi.nlm.nih.gov/pubmed/36636441
http://dx.doi.org/10.1016/j.jaccao.2022.11.004

Ejemplares similares